These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35156207)
21. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. Selby LV; Ejaz A; Brethauer SA; Pawlik TM Expert Opin Investig Drugs; 2020 Feb; 29(2):107-110. PubMed ID: 31986920 [No Abstract] [Full Text] [Related]
22. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. Azzu V; Vacca M; Virtue S; Allison M; Vidal-Puig A Gastroenterology; 2020 May; 158(7):1899-1912. PubMed ID: 32061598 [TBL] [Abstract][Full Text] [Related]
23. Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease. Saran AR; Dave S; Zarrinpar A Gastroenterology; 2020 May; 158(7):1948-1966.e1. PubMed ID: 32061597 [TBL] [Abstract][Full Text] [Related]
24. Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH). Schattenberg JM Expert Opin Investig Drugs; 2020 Feb; 29(2):111-113. PubMed ID: 31985310 [No Abstract] [Full Text] [Related]
26. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. Hannah WN; Harrison SA Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273 [TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease and cardiovascular disease. Liu H; Lu HY World J Gastroenterol; 2014 Jul; 20(26):8407-15. PubMed ID: 25024598 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. Samala N; Tersey SA; Chalasani N; Anderson RM; Mirmira RG J Diabetes Complications; 2017 Nov; 31(11):1630-1637. PubMed ID: 28886991 [TBL] [Abstract][Full Text] [Related]
29. NASH Syndrome: The Coming Epidemic. Dominguez C Gastroenterol Nurs; 2018; 41(4):316-320. PubMed ID: 30063688 [TBL] [Abstract][Full Text] [Related]
30. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Polyzos SA; Kountouras J; Mantzoros CS Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373 [TBL] [Abstract][Full Text] [Related]
35. Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet. Mendes IKS; Matsuura C; Aguila MB; Daleprane JB; Martins MA; Mury WV; Brunini TMC Appl Physiol Nutr Metab; 2018 Jan; 43(1):23-29. PubMed ID: 28834687 [TBL] [Abstract][Full Text] [Related]
36. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial. Winn NC; Liu Y; Rector RS; Parks EJ; Ibdah JA; Kanaley JA Metabolism; 2018 Jan; 78():128-140. PubMed ID: 28941598 [TBL] [Abstract][Full Text] [Related]
37. Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. Simoes ICM; Janikiewicz J; Bauer J; Karkucinska-Wieckowska A; Kalinowski P; Dobrzyń A; Wolski A; Pronicki M; Zieniewicz K; Dobrzyń P; Krawczyk M; Zischka H; Wieckowski MR; Potes Y Nutrients; 2019 Nov; 11(12):. PubMed ID: 31771244 [TBL] [Abstract][Full Text] [Related]
38. Cutting out the liver fat. Nat Med; 2017 Dec; 23(12):1385. PubMed ID: 29216035 [No Abstract] [Full Text] [Related]
39. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. Milić S; Lulić D; Štimac D World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327 [TBL] [Abstract][Full Text] [Related]
40. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. Oliveira CP; de Lima Sanches P; de Abreu-Silva EO; Marcadenti A J Diabetes Res; 2016; 2016():4597246. PubMed ID: 26770987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]